Valsartan Recall: FDA Adds More Firms in Recall of Blood Pressure Drug

In this undated photo, the FDA has expanded its recall of valsartan. NTD TV secreenshot

More companies were added to a U.S. Food and Drug Administration recall of blood pressure and heart medicine containing a possible carcinogen, according to an update on Aug. 8.

Valsartan, according to the FDA, is used as a component in drugs that is to treat high blood pressure as well as congestive heart failure. The FDA initiated its first recall July 13 after tests showed the drugs could contain N-Nitrosodimethylamine (NDMA).